Skip to Content

Trxade Health Inc MEDS

Morningstar Rating
$8.22 −0.28 (3.29%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

MEDS is trading at a 58% discount.
Price
$8.28
Fair Value
$23.24
Uncertainty
Extreme
1-Star Price
$828.89
5-Star Price
$3.18
Economic Moat
Smyj
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if MEDS is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$8.50
Day Range
$7.918.42
52-Week Range
$3.6919.70
Bid/Ask
$7.88 / $8.49
Market Cap
$9.91 Mil
Volume/Avg
52,199 / 267,724

Key Statistics

Price/Earnings (Normalized)
Price/Sales
0.92
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Trxade Health Inc is a health service IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey, and patient engagement in the U.S. Its product and services include Integra Pharma Solutions, LLC, Community Specialty Pharmacy, LLC, Delivmeds.com, Bonum Health Hub and Application, and others. its business is classified into reportable segments which are Trxade, Inc, Community Specialty Pharmacy, LLC, Integra Pharma, LLC, and Other, and the majority of the revenue comes from Trxade, Inc.
Sector
Healthcare
Industry
Pharmaceutical Retailers
Stock Style Box
Small Core
Total Number of Employees
34

Valuation

Metric
MEDS
Price/Earnings (Normalized)
Price/Book Value
0.29
Price/Sales
0.92
Price/Cash Flow
Price/Earnings
MEDS

Financial Strength

Metric
MEDS
Quick Ratio
0.25
Current Ratio
0.61
Interest Coverage
−4.72
Quick Ratio
MEDS

Profitability

Metric
MEDS
Return on Assets (Normalized)
−34.98%
Return on Equity (Normalized)
−101.17%
Return on Invested Capital (Normalized)
−40.54%
Return on Assets
MEDS
See how this stock stacks up to its competitors with Morningstar Investor

Pharmaceutical Retailers Industry Comparables

Sponsor Center